Fibrobiologics, Inc.
SEC CIK 1958777 · FBLG · last insider filing 2026-06-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hoffman Robert E. | Director | filed 2024 - 2026 |
| Link Matthew | Director | filed 2024 - 2026 |
| Cilento Richard C. Jr. | Director | filed 2024 - 2026 |
| Niklas Victoria Ninon Olivia | Director | filed 2024 - 2026 |
| O'Heeron Pete | Director · Chief Executive Officer | filed 2024 - 2026 |
| Coen Stacy Ann | Director | filed 2024 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Davis Jason | Chief Financial Officer | filed 2025 - 2026 |
| Khoja Hamid | Chief Scientific Officer | filed 2024 - 2026 |
| Garcia Ruben A | General Counsel | filed 2024 - 2026 |
| Andersen Mark C. | Chief Financial Officer | filed 2024 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.